MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 03-14-2026
Insulet Corporation Total Shareholders Equity 2011-2026 | PODD
Annual Total Shareholders Equity Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.52 B | 1.21 B | 733 M | 476 M | 556 M | 604 M | 75.9 M | 212 M | 158 M | 63.2 M | 34.1 M | 83.8 M | 125 M | 44.2 M | 82.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.52 B | 34.1 M | 398 M |
Quarterly Total Shareholders Equity Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.38 B | 1.46 B | 1.33 B | 1.21 B | 1.12 B | 998 M | 791 M | 733 M | 608 M | 554 M | 503 M | 476 M | 428 M | 422 M | 447 M | 556 M | 498 M | 459 M | 585 M | 604 M | 595 M | 563 M | 59 M | 75.9 M | 151 M | 250 M | 224 M | 212 M | 212 M | 212 M | 212 M | 158 M | 159 M | 159 M | 159 M | 63.1 M | 63.2 M | 63.2 M | 63.2 M | 34.1 M | 34.1 M | 34.1 M | 34.1 M | 83.8 M | 83.8 M | 83.8 M | 83.8 M | 125 M | 125 M | 125 M | 125 M | 44.2 M | 44.2 M | 44.2 M | 44.2 M | 82.7 M | 82.7 M | 82.7 M | 82.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.46 B | 34.1 M | 344 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Medtronic PLC
MDT
|
48 B | $ 87.12 | 0.62 % | $ 112 B |  USA |
 |
BioSig Technologies
BSGM
|
-1.54 M | - | 37.08 % | $ 85.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.13 | 6.22 % | $ 1.29 M | USA |
 |
Orthofix Medical
OFIX
|
450 M | $ 11.97 | 2.13 % | $ 474 M |  Curacao |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
192 M | $ 6.3 | -0.4 % | $ 168 M | USA |
 |
IRadimed Corporation
IRMD
|
94.6 M | $ 102.82 | 1.83 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
LENSAR
LNSR
|
4.86 M | $ 5.66 | 1.8 % | $ 65.2 M | USA |
 |
AxoGen
AXGN
|
129 M | $ 33.16 | 1.69 % | $ 1.53 B | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 36.85 | 0.72 % | $ 1.14 B | USA |
 |
AVITA Medical
RCEL
|
-16.6 M | $ 4.04 | 5.21 % | $ 113 M |  Australia |
 |
NanoVibronix
NAOV
|
627 K | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 24.7 | 0.2 % | $ 209 M | USA |
 |
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
11.1 M | $ 0.65 | -7.27 % | $ 35.4 M | USA |
 |
Aethlon Medical
AEMD
|
5.12 M | $ 2.25 | 3.94 % | $ 3.51 M | USA |
 |
InspireMD
NSPR
|
55.2 M | $ 1.79 | 1.13 % | $ 115 M |  Israel |
 |
Profound Medical Corp.
PROF
|
97.4 M | $ 5.23 | 1.55 % | $ 180 M | Canada |
 |
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
2.93 M | $ 2.62 | 1.95 % | $ 7.27 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.52 B | $ 11.61 | 1.13 % | $ 1.57 B | USA |
 |
Myomo
MYO
|
11.4 M | $ 0.72 | 3.24 % | $ 30.1 M | USA |
 |
Smith & Nephew plc
SNN
|
5.28 B | $ 32.46 | 0.92 % | $ 23.8 B |  Britain |
 |
Penumbra
PEN
|
1.43 B | $ 335.79 | 0.46 % | $ 13.1 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
189 M | $ 2.4 | - | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
81.1 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 3.69 | -5.63 % | $ 138 M |  France |
 |
Sensus Healthcare
SRTS
|
48.1 M | $ 3.96 | - | $ 64.7 M | USA |
 |
Quanterix Corporation
QTRX
|
296 M | $ 3.95 | 3.4 % | $ 168 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 16.04 | 0.82 % | $ 376 M | USA |
 |
Outset Medical
OM
|
127 M | $ 3.56 | 0.85 % | $ 54.2 K | USA |